Humacyte, Inc

2017

Humacyte 2016 Fierce Innovation Awards Finalist

Humacyte is a regenerative medicine company focused on vascular therapies. Yale University’s Laura Niklason cofounded Humacyte in 2004 to develop and commercialize technology to grow bioengineered blood vessels—and potentially other human tissues—in the laboratory.

Read More »

2016

CNBC Disruptor 50 List

See our press release and video announcing the recognition of Humacyte in the CNBC Disruptor 50 list, a list of private companies “whose innovations are revolutionizing the business landscape”. We are very pleased to be included along side companies like Uber, Airbnb, and 23andMe.

Carrie Cox, President and CEO
Humacyte, Inc.

Read More »

2015

North Carolina Excellence Award

Humacyte, an innovator in biotechnology and regenerative medicine, announced today that the Company has been awarded the 2015 North Carolina Excellence Award by the US Commerce & Trade Research Institute (USCTRI), a leading research authority that evaluates and recognizes businesses and organizations that have made a significant contribution in enterprise and entrepreneurial growth.

Read More »

2013

Excellence in Commerce Award

The Small Business Institute for Excellence in Commerce (SBIEC) recognizes Humacyte with the 2013 North Carolina Excellence Award for continued advancement of business leadership and high regard for upholding business ethics and company values among its peers.

Read More »

2012

Photo of Carrie S Cox

Top 10 Women in Biotech

Fierce Biotech names Carrie Cox as one of the “Top 10 Women in Biotech”

Read More »
Fast Company

Fast Company Top 50 World’s Most Innovative Companies

Fast Company names Humacyte as one of the “Top 50 World’s Most Innovative Companies”

Read the Article

2011

Cover of Popular Mechanics

Popular Mechanics Breakthrough Innovation of 2011

Popular Mechanics recognizes Humacyte investigational bioengineered blood vessel technology as a “Breakthrough Innovation of 2011.” This technology is under clinical study by Humacyte, and Humacyte plans to seek FDA approval of the technology.

Read More »
Frost & Sullivan Award Presentation

Frost & Sullivan New Product Innovation

Humacyte receives Frost & Sullivan Award for New Product Innovation

Read More »